Literature DB >> 28741452

Young Age and Male Sex Are Predictors of Large-Volume Central Neck Lymph Node Metastasis in Clinical N0 Papillary Thyroid Microcarcinomas.

Hye-Seon Oh1, Suyeon Park1, Mijin Kim1, Hyemi Kwon1,2, Eyun Song1, Tae-Yon Sung3, Yu-Mi Lee3, Won Gu Kim1, Tae Yong Kim1, Young Kee Shong1, Won Bae Kim1, Min Ji Jeon1.   

Abstract

BACKGROUND: Large-volume lymph node metastasis (LNM) is associated with poor clinical outcomes in papillary thyroid microcarcinoma (PTMC) patients. However, sensitivity in the detection of central neck LNM on preoperative neck ultrasonography (US) is believed to be low. The aim of this study is to investigate the preoperative clinical factors associated with large-volume LNM in clinical N0 PTMC patients.
METHODS: In all, 2329 clinical N0 PTMC patients who underwent total thyroidectomy with prophylactic central lymph node (LN) dissection were evaluated. The LNM status of these patients was divided into three groups by the number of metastatic nodes: no LNM, small-volume LNM (≤5 metastatic LNs), and large-volume LNM (>5 metastatic LNs). The correlations between age, sex, and other clinical factors and large-volume LNM were evaluated.
RESULTS: Large-volume LNM was found in 94 (4.0%) patients. Young (<40 years old) and male patients tended to have large-volume LNM (p for trend <0.001). Young age (odds ratio [OR] = 2.69 [confidence interval (CI) 1.64-4.32], p < 0.001) and male sex (OR = 5.79 [CI 3.67-9.10], p < 0.001) were independent risk factors for large-volume LNM in multivariate analyses. The prevalence of large-volume LNM ranged from 24% in male patients <40 years of age to only 2% in female patients aged ≥40 years. Multifocal tumors and presence of extrathyroidal extension were also considered risk factors for large-volume LNM.
CONCLUSIONS: Large-volume LNM was more frequently found in young (<40 years) and male patients. These findings support the notion that surgery rather than observation may be favored in young and male clinically LN negative PTMC patients as a primary therapeutic option.

Entities:  

Keywords:  lymph node metastasis; male; papillary thyroid microcarcinoma; young age

Mesh:

Year:  2017        PMID: 28741452     DOI: 10.1089/thy.2017.0250

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  33 in total

1.  A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.

Authors:  Zhong Ying Rui; Yang Liu; Wei Zheng; Xuan Wang; Zhao Wei Meng; Jian Tan; Ning Li; Qiang Jia
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

2.  Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis.

Authors:  Se Jin Cho; Sun Mi Baek; Dong Gyu Na; Kang Dae Lee; Young Kee Shong; Jung Hwan Baek
Journal:  Eur Radiol       Date:  2021-03-13       Impact factor: 5.315

3.  Treatment Variation in Older Adults With Differentiated Thyroid Cancer.

Authors:  Whitney Sutton; Joseph K Canner; Dorry L Segev; Martha A Zeiger; Aarti Mathur
Journal:  J Surg Res       Date:  2020-05-21       Impact factor: 2.192

Review 4.  [Surgery of papillary thyroid microcarcinoma].

Authors:  T Weber; S Peth; R Hummel
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 5.  Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?

Authors:  Min Ji Jeon; Won Gu Kim; Ki-Wook Chung; Jung Hwan Baek; Won Bae Kim; Young Kee Shong
Journal:  Eur Thyroid J       Date:  2019-09-25

6.  Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma.

Authors:  Cui Zhang; Bao-Jun Li; Zhao Liu; Ling-Ling Wang; Wen Cheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-13       Impact factor: 2.503

7.  Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaodong He
Journal:  Gland Surg       Date:  2020-06

8. 

Authors:  文 刘; 治中 董; 艳军 苏; 云海 马; 建明 张; 畅 刁; 军 钱; 若川 程
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

9.  Risk probability model for residual metastatic lymph node in patients with papillary thyroid microcarcinoma undergoing cervical central lymph node dissection.

Authors:  Wen Liu; Zhizhong Dong; Yanjun Su; Yunhai Ma; Jianming Zhang; Chang Diao; Jun Qian; Ruochuan Cheng
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

10.  Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy.

Authors:  Jianhao Huang; Muye Song; Hongyan Shi; Ziyang Huang; Shujie Wang; Ying Yin; Yijie Huang; Jialin Du; Sanming Wang; Yongchen Liu; Zeyu Wu
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.